Amanda Forys Speaks to AJMC on Reimbursement Models and Formulary Placement Strategies for Biosimilars

August 1, 2017

Xcenda's Amanda Forys, MSPH, Director of Reimbursement Policy Insights, speaks with the American Journal of Managed Care (AJMC) and discusses reimbursement models and formulary placement strategies for biosimilar products. Ms. Forys provides insights on how biosimilars products can affect the development of new reimbursement models and formulary placement strategies as more people become educated on biosimilars.

 

Click here to View the article and interview with Amanda Forys.